Policy agents as catalysts of knowledge links in the biotechnology sector by Trippl, Michaela et al.
ePubWU Institutional Repository
Michaela Trippl and Joshua von Gabain and Franz Tödtling
Policy agents as catalysts of knowledge links in the biotechnology sector
Working Paper
Original Citation:
Trippl, Michaela and Gabain, Joshua von and Tödtling, Franz (2006) Policy agents as catalysts
of knowledge links in the biotechnology sector. SRE - Discussion Papers, 2006/01. Institut für
Regional- und Umweltwirtschaft, WU Vienna University of Economics and Business, Vienna.
This version is available at: http://epub.wu.ac.at/1742/
Available in ePubWU: March 2006
ePubWU, the institutional repository of the WU Vienna University of Economics and Business, is
provided by the University Library and the IT-Services. The aim is to enable open access to the
scholarly output of the WU.
http://epub.wu.ac.at/
 Institut für Regional- und Umweltwirtschaft 
Institute of Regional Development and Environment 
Michaela Trippl, Joshua von Gabain, Franz Tödtling 
 
Policy agents as catalysts of knowledge links in the  
biotechnology sector 
 
 
 
SRE-Discussion 2006/01 2006 
  
Policy agents as catalysts of knowledge links in the 
biotechnology sector 
 
 
 
 
 
Michaela Trippl, Joshua von Gabain and Franz Tödtling 
 
 
Institute for Regional Development and Environment 
Vienna University of Economics and Business Administration 
UZA 4, Nordbergstraße 15, A-1090 Vienna, Austria 
 
 
 
Draft version 
 
 
 
 
January 2006 
 
 
Abstract 
The purpose of this paper is to explore the role of public policy in promoting 
interorganisational knowledge links in the biotechnology sector. Despite the significance of 
such interactions and the policy efforts devoted to them, there is a limited understanding of 
how different initiatives from various policy levels contribute to the formation of specific 
knowledge linkages within the biotechnology industry. The paper identifies four main types 
of knowledge exchange, including market relations, spillovers, formal co-operations and 
informal networking. Drawing on evidence from the Vienna biotechnology cluster we intend 
to show how national and regional policy programmes and government actions function as 
mechanisms to stimulate the establishment of such interactions. 
 
 
 1 
1 Introduction 
Biotechnology is acknowledged to be one of the key sectors of the emerging knowledge 
economy (Cooke 2002b, OECD 2004). Many studies have shown that government services 
and programmes are of utmost significance in moving the biotechnology sector forward 
(Reiss et al. 2003, Lofgren and Benner 2005). The crucial tasks of public policy include 
amongst others the funding of universities and the R&D system, training and education, 
support for entrepreneurship, and the commercialisation of science, arrangements to ensure 
the availability of finance, changes to taxation systems, and intellectual property rights. Policy 
makers are also key agents for facilitating knowledge sharing and networking in the 
innovation process. Despite the significance of knowledge links in biotechnology and the 
policy efforts devoted to them, there is still a limited understanding of how different 
initiatives from various policy levels contribute to the formation of such ties. In this paper an 
attempt is made to shed some light on this topic by dealing with the following research 
questions: 
 
· What is the role of the state in developing the biotechnology industry?  
· Which types of knowledge interactions are of importance in the Vienna biotechnology 
cluster and what is the particular spatiality of these linkages? 
· How can different government initiatives and policy levels encourage the formation and 
functioning of knowledge interactions in this sector? 
 
The structure of this paper is as follows. Section 2 deals with the role of the state for 
promoting innovation and growth in the biotechnology sector. Then we identify different 
types of knowledge interactions, distinguishing between market relations, spillovers, formal 
co-operations and informal networks. In Section 3 the main structuring of the Vienna 
biotechnology cluster as well as its knowledge links and their particular geography are 
investigated. Section 4 provides an overview on policy measures that are geared towards the 
stimulation of various  types of knowledge links in this cluster. Finally, Section 5 summarises 
the main results and draws some conclusions. 
 
 
 2 
2 Theoretical framework and literature review 
2.1 Biotechnology policy 
In the meantime there exists a large body of work dealing with the role of public policy in 
nurturing the development of biotechnology. Biotechnology is considered to be critically 
dependent on state intervention (Cooke 2004a, Lofgren and Benner 2005). As Bagchi-Sen et 
al. (2004: 201) put it: “This is an industry in which government policy plays an important role 
in almost every state of research, development, and commercialisation ... the experience from 
the past two decades shows that stable and supportive federal, as well as state and local, 
policy environments are necessary for the growth of this industry.” A number of studies has 
demonstrated that even in less interventionist countries such as the USA, the biotech industry 
is heavily supported by federal and state government programmes and actions (Prevezer 2001, 
Audretsch 2003, Feldman and Francis 2003, Bagchi-Sen et al. 2004). Also many European 
countries and regions adopted explicit policies to promote the biotechnology sector (see, for 
example, Kaiser 2003, Reiss et al. 2003, van Geenhuizen 2003, Cooke 2004a, 2004b, 
Leibovitz 2004, Lehrer and Asakawa 2004, Eickelpasch and Fritsch 2005). 
 
There is a widespread agreement in the literature that public funding of scientific R&D at 
universities and other research organisations is crucial for the evolution of the biotech 
industry (McMillan, Narin and Deeds 2000, Lofgren and Benner 2005). Indeed, a strong 
research base and the existence of world-class scientific talent constitute the common element 
in the origins of the firms in biotechnology clusters (Galambos and Sewell 1996). Prevezer 
(2001) concludes from her analysis of the early development of the U.S. biotech sector that it 
was the funding of the medical science base rather than of the biotech industry directly that 
has provided the foundations for start-ups to be created out of the science base. Research 
activity alone, however, is not enough to ensure the growth of this sector. There must also 
exist favourable conditions for the commercialisation of basic research (Audretsch 2003, 
Bagchi-Sen et al. 2004). To secure a steady flow of knowledge from academia to industry is a 
key challenge for policy makers. This holds in particular true for many European nations and 
regions as they traditionally lack such a close integration between industry and academia as it 
could be observed in the USA (Henderson, Orsenigo and Pisano 1999, Owens-Smith, 
Riccaboni, Pammolli and Powell 2003, Lehrer and Asakawa 2004). A favourable 
environment for commercialising scientific research rests on several key factors (Audretsch 
2003), including the availability of venture capital and other forms of finance, a strong 
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entrepreneurial culture and regulations not hampering start-up and growth processes. These 
and other ingredients of successful biotech clusters such as an excellent stock of human 
capital or favourable legislative frameworks governing research and market structures, etc. 
also represent important fields for policy actions. There are several core themes in the 
literature that are related to the role of the state in biotechnology. 
 
· There seems to be a growing consensus among many scholars that developing high tech 
industries cannot be done with old policy recipes and traditional instruments such as tax 
incentives, cheap land, low-costs labour and relocation subsidies (Audretsch 2003, 
Feldman and Francis 2004). New industries need new policy strategies such as fostering 
entrepreneurship and stimulating networks. This is corroborated by Cooke (2002b) who 
points out that public policies to foster the knowledge economy should not only cover 
investments in hard infrastructure, such as transportation and communication systems, but 
also in knowledge infrastructures, such as universities, research institutes, science parks, 
and technology-transfer centres.  
· This observation is related to a new role of the state. There is a shift towards public policy 
for the purpose of co-ordination and facilitation within networks. Negotiations and 
interdependencies within networks provide the mechanisms for policy development and 
implementation, rather than hierarchy and commands (Lemke and Östohl 2005, Lofgren 
and Benner 2005).  
· Furthermore, there is also the question of the appropriate level of policy intervention. 
Whilst not neglecting the importance of the national policies, in recent years many authors 
have argued that the regional policy level is also crucial for fostering high- tech 
development (Cooke 2004a, Lemke and Östhol 2005). Indeed, there seems to be a trend 
towards public sector decentralisation that has enabled local and regional governments to 
launch programmes to cluster development in sectors such as biotechnology (Asheim and 
Gertler 2005, Lofgren and Benner 2005).The effective division of labour between the 
national and regional policy level, however, remains little understood. 
· There seems to be some consensus in the literature that biotech clusters cannot be built 
from scratch or by fiat (Feldman and Francis 2004). Case studies of the formation of 
industrial clusters suggest that a complex, self-organising process is at work (Feldman 
2000, Feldman and Francis 2004). The formation of clusters can only be facilitated and 
stimulated, but not directed, by policy makers. 
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These are fairly relevant and interesting topics that capture many aspects of the influence of 
the public sector on biotechnology. What is missing so far in the literature is a systematic 
overview on how governments can and should promote different types of knowledge 
interactions in this sector. To be sure, there is an intensive discussion on the promotion of 
spin-offs as new firm formation is a critical element in the emergence and development of 
high-tech clusters such as biotechnology (Feldman, Francis and Bercovitz 2005). The 
comprehension of this process has become a matter of major interest in the recent past. This 
holds in particular true for academic spin-off ventures (Roberts and Melone 1996, Wright, 
Birley and Mosey 2004, Degroof and Roberts 2004). In order to foster entrepreneurship in 
biotechnology many states and regions have launched a large variety of support actions. The 
promotion of collaboration and networking by policymakers is also well documented in 
literature (Reiss et al. 2003). Spin-offs and formal networks, however, are only two forms of 
knowledge interactions in a broader set of such links. Policymakers must be aware that in the 
biotechnology sector knowledge is exchanged in various ways and they must have an idea of 
the relevance of the different types of knowledge links and of their geography. In the next 
section, we will provide such a taxonomy of knowledge interactions. 
 
2.2 Knowledge links in biotechnology 
In the recent past the knowledge base of biotechnology has attracted considerable research 
interest. It has been shown that knowledge base of the biotech industry is extremely complex, 
expanding rapidly, and the sources of expertise and knowledge are widely dispersed (Powell, 
Koput and Smith-Doerr 1996, Powell 1998). Consequently, all the necessary competencies 
needed to innovate successfully in biotechnology can hardly be found under a single roof. 
External knowledge sources and interorganisational linkages play an outstanding role. Their 
number and scope have grown rapidly over the last years (McKelvey 2004). The large-scale 
reliance on interorganisational ties can be seen as the outcome of a fundamental and pervasive 
concern with access to expertise and knowledge (Powell 1998). The character of those links 
and their spatiality, however, have still to be clarified (Gertler and Levitte 2003, Tödtling and 
Trippl 2005). While some authors argue that geographically localised knowledge spillovers 
from universities play an outstanding role (Zucker, Darby and Brewer 1998b, Keeble and 
Wilkinson 2000, Feldman 2001, Prevezer 2001), others stress that there is a dominance of 
contractual arrangements and embodied technology transfer through markets (Zucker, Darby 
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and Armstrong 2002, Gertler and Levitte 2003). Zucker, Darby and Armstrong (1998a) note 
that university scientists do not give away their knowledge freely but instead enter into 
contractual arrangements with enterprises or start their own firm in order to commercialise 
their scientific discoveries. Interestingly, they found that scientists work with or create firms 
within commuting distance of home or university, thus creating localised effects of university 
research. Another stream of literature also emphasises that biotechnology is characterised by a 
high proportion of formal alliances (Arora and Garmbardella 1990, Garmbardella 1995), 
covering university- industry links and inter- firm R&D partnerships such as those between 
large pharmaceutical companies and small biotechnology firms (Shan, Walker and Kogut 
1994, Hagedoorn and Roijakkers 2002). Several studies on innovation networks have shown 
that there is some networking at the regional and national levels, often involving local 
universities, venture capitalists and smaller companies (Cooke 2002b, Powell, Koput, Bowie 
and Smith-Doerr 2002). However, more frequently the networks were among international 
partners (Hagedoorn 2002, McKelvey, Alm and Riccaboni 2003, Owen-Smith and Powell 
2004) nurturing the view that non-local linkages are crucial. Recently, the argument has been 
put forward that both extensive relations within local clusters and strong connections to 
national and global knowledge sources are highly relevant (Gertler and Levitte 2003, Bathelt, 
Malmberg and Maskell 2004). This view clearly challenges the assumption of the dominance 
of one spatial level over another. On the contrary, Bathelt, Malmberg and Maskell (2004) 
have pointed out that “global pipelines” should be seen as important complements to the 
“local buzz” generated in clusters. Overall, in the literature there is thus a lack of consensus 
on the specific nature of knowledge flows and their geography. It is still unclear to which 
extent innovation in biotechnology is based on market relations, formal networks or spillovers 
and milieu effects. Furthermore, the issue whether these relations are local or global is far 
from being resolved and also the relation between these different spatial scales remains poorly 
understood. A further problem that has arisen from the literature discussed above is that it is 
not always clear what is meant by knowledge spillovers, market relations and networks. In the 
following we will present a model of knowledge flows which enables us to draw a clear 
distinction between these concepts.  
 
In order to get a better understanding of the nature of knowledge flows in biotechnology we 
propose a taxonomy of interactions (see Tödtling, Lehner and Trippl 2005) that rests on two 
crucial dimensions (see Figure 1). The first dimension refers to a differentiation between 
traded and untraded interdependencies (see Storper 1997) in the innovation process. In traded 
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and formal relations there are monetary or other forms of compensation for particular 
knowledge flows, whereas in non-traded and informal relations there is no specific immediate 
compensation. The second dimension refers to the static versus dynamic aspects of knowledge 
exchange and innovation interactions (Camagni 1991, Maillat 1998, Capello 1999). Static 
knowledge exchange here means the transfer of “ready” pieces of information or knowledge 
from one actor to the other. Dynamic knowledge exchange refers to a situation, where there is 
interactive learning among actors through, e.g., cooperation or other joint activities (Lundvall 
1992, Camagni 1991, Capello 1999, Lawson 2000). In this case the collective stock of 
knowledge is increased through the interaction. This classification provides us with the 
following four main types of relations (Figure 1) 
 
Figure 1: Types of relations in the innovation process 
 
 Static 
(knowledge transfer) 
Dynamic 
(collective learning) 
formal /  
traded relation 
market 
relations 
cooperation /  
formal networks 
informal / 
untraded relation 
knowledge externalities and 
spillovers 
milieu 
informal networks 
 
Source: Tödtling, Lehner, Trippl (2005) 
 
We have to consider that these four types of relations constitute “ideal types” which in real 
situations can rarely be observed in pure form. In fact many concrete knowledge links are in 
between these ideal forms and often there may exist combinations of these types. 
 
Market relations: Market relations in the present context refer to the buying of “embodied” 
technology and knowledge in various forms. This includes the buying of machinery, ICT 
equipment or software, contract research or the buying of licenses. Since the traded 
technology or knowledge is more or less in a “ready” form, we consider this as a static 
relation or knowledge transfer. Trade partners could be changed swiftly and the level of 
interaction is often low. A number of studies have shown that the traded relations are usually 
at higher spatial levels, reaching clearly beyond the region (Storper 1997, Sternberg 2000). 
Policy actors can play a strong role in facilitating the formation of market relations. Key 
activities in this respect include, for example, the promotion of technology transfer from 
universities to industry by stimulating contract research at academic institutions or the 
creation of favourable framework conditions and incentives for patenting and licensing 
scientific discovering. 
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Local knowledge externalities or spillovers: A number of scholars have demonstrated 
through econometric methods that there are considerable local knowledge externalities or 
spillovers in particular from universities and research organisations to firms. Jaffe (1989), 
Audretsch and Feldman (1996), Anselin, Varga and Acs (1997) and Bottazi and Peri (2003) 
investigated local knowledge spillovers applying a knowledge production function approach. 
Jaffe, Trajtenberg and Henderson (1993) found considerable proximity effects with respect to 
patent citations. Local knowledge spillovers result from various kinds of mechanisms such as 
knowledge transfer, e.g. through spin-offs and mobile labour, through face-to-face contacts or 
simply through “monitoring” of competitors (Malmberg and Maskell 2002). To strengthen 
university research and to intensify positive externalities and spillovers by facilitating 
academic spin-offs or by promoting the inflow of highly skilled and experienced workers into 
the local industry turn out to be important elements of cluster initiatives in biotechnology. 
 
Networks: Compared to market links, networks are more durable and interactive relations. 
There is not just an exchange of a given technology or piece of knowledge but a collective 
further development and an increase of the respective knowledge base, constituting a dynamic 
process of collective learning (Lundvall and Johnson 1994). Innovation networks are set up 
between specific partners and may take different forms (DeBresson and Amesse 1991, Powell 
and Grodal 2005). Some are based on formal agreements or contracts (R&D-cooperation, 
alliances, research-consortia) including formal statements on the sharing of tasks, cost, 
benefits and revenues. Since the search of partners is highly selective and targeted on specific 
strategic or complementary competences, formal innovation networks are often at an 
international scale (Archibugi and Iammarino 1999). In those cases where various barriers 
hinder the spontaneous emergence of such formal networks, policy makers can play a 
powerful role in spurring on the development of such linkages, e.g. by promoting university-
industry partnerships and other types of research cooperations. 
 
Informal links and milieu: Innovation networks may also include more informal links among 
companies and organisations (Saxenian 1994). These are based on trust, a shared 
understanding of problems and objectives, and the acceptance of common rules and 
behavioural norms. Although for a knowledge flow usually there is no formal and monetary 
compensation, some form of reciprocity exists in the long run. This is referred to as social 
capital (Putnam 1993, Wolfe 2002) or a shared culture leading to a specific innovative milieu 
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(Camagni 1991). The rapid exchange of ideas and knowledge are key to an innovative milieu, 
but there is also a dynamic aspect of a collective enhancement of the local knowledge base, 
resulting in collective learning (Camagni 1991, Capello 1999, Lawson 2000). To promote 
social capital and regional dialogue and, thus, an intense informal exchange of ideas and 
expertise by bringing, for instance, firms and academics together at meetings or fairs might be 
crucial policy measures in order to encourage innovation in the local biotechnology cluster. 
 
The taxonomy of knowledge links presented above also allows us to be more specific about 
the role of governments in promoting innovation interactions in biotechnology. We might 
differentiate between the following functions of policy agents:  
 
· facilitators of market links, 
· intensifier of positive externalities, 
· supporters of networks, and 
· animators of milieu-effects. 
 
To be sure, these reflections on the role of policy as promoter of knowledge links are not only 
inspired by the “classical” concept of market failure. Instead, the arguments put forward here 
draw on a new rationale for policy making, covering also “systemic” failures (OECD 1999, 
Edquist 2002, Lundvall and Borrás 1999, 2005) which could block the functioning of clusters 
and innovation systems and hinder the flow of knowledge and technology. Consequently, 
inappropriate interactions, the lack of communication and networking are seen to constitute 
important deficiencies which justify public intervention. 
 
In the following two chapters we will explore for the Vienna biotechnology cluster the nature 
and geography of knowledge links as well as the role of public policies in promoting such 
ties. 
 
3 The Vienna biotechnology cluster: Structuring and knowledge links 
The Austrian biotech sector features a specific pattern of specialisation as there is a clear 
dominance of medical (“red”) biotechnology (Baier et a. 2000, Oosterwijk et al. 2003). 
Austria has to be regarded as a latecomer in the commercialisation of biotechnology. 
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Although there is a good scientific base the commercial exploitation of research results is 
underdeveloped (Reiss et al. 2003). This is mainly due to weak incentives and conditions for 
commercialising research and a lack of tradition and culture for high-risk taking. The Austrian 
biotechnology sector features a strong tendency toward spatial concentration. Almost 70% of 
all biotech related firms are located in the Vienna region. Smaller clusters of biotechnological 
activities can be found in the provinces of Styria, Lower Austria and Tyrol (see Table 1). In 
the following the main structuring of the Vienna biotech cluster will be analysed. 
 
Table 1: Proportion of biotechnology related companies in different Austrian provinces 
 
Region Number of firms  Proportion of firms (%) 
Vienna 77 67 
Styria 10 8,7 
Lower Austria 10 8,7 
Tyrol 9 7,8 
Upper Austria 4 3,5 
Salzburg 4 3,5 
Vorarlberg 1 0,8 
Burgenland 0 0 
Carinthia 0 0 
Total 115 100 
Source: BIT (2004)1, complemented by our own inquiry 
 
3.1 Structuring of the Vienna biotechnology cluster 
The Vienna region is Austria’s most important centre for medical biotechnology, hosting 
about 80 biotechnology related firms. Key fields of activity in this cluster include therapeutics 
and specialised supply whereas diagnostics play only a minor role. The structure of the cluster 
is characterised by the existence of 6 subsidiaries of foreign big pharma companies, 25 small 
dedicated biotechnology companies, and several specialised and other suppliers (see Table 2). 
 
Table 2: Classification of biotechnology related firms in three Austrian clusters 
 
 Vienna 
 Number 
of firms  
Proportion 
of firms (%) 
Multinational Companies 6 8 
Dedicated Biotech Firms  25 32,4 
Specialis ed Suppliers 19 24,6 
Other Suppliers 10 13 
Other Firms  2 2,6 
Sales and Distribution Firms  15 19,4 
Total 77 100 
Source: BIT (2004), complemented by our own inquiry 
                                                 
1 http://www.bit.or.at/bioaustria/index.php 
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There is a long time presence of subsidiaries of multinational companies in the region which 
had been attracted by the strong research base and the easy recruitment of highly skilled 
scientists. Boehringer Ingelheim settled down in 1949, Novartis arrived in 1969 and Baxter 
opened its doors in 1983. Boehringer Inge lheim Austria includes the company’s center for 
cancer research, one of its two centers of competence in biopharmaceutical production and its 
basic research subsidiary IMP. Novartis is the nation’s largest pharmaceutical producer with a 
total of more than 3.000 workers. Baxter Austria is the company’s most important research 
operation outside the U.S. Another key actor is Eli Lilly which mainly carries out clinical 
research projects in the area. Furthermore, there are about 15 sales and distribution firms 
located in Vienna. Among these are subsidiaries of Amgen, Aventis, Behring and Schering 
that all see the region as sales and distribution centre for the Eastern European market. The 
Vienna region hosts about 25 dedicated biotech companies. Examples include Intercell 
(vaccines against oncological and infectious diseases), Igeneon (oncology) which has recently 
been acquired by the US biopharmaceutical company Aphton, Austrianova (oncology, gene 
therapy) or Green Hills Biotechnology (oncology). About 40 % of the dedicated biotech firms 
were founded within the past 5 years and many of them employ less than 10 workers. There 
are about 20 specialised suppliers operating in the area. This segment mainly consists of 
producers of research agents (Bender Med Systems, Nano-S), bioinformatics providers 
(Emergentec, Insilico) and firms performing clinical trials services. Finally, there are 10 
suppliers offering laboratory products and equipment. Venture capital firms and business 
angels are a missing ingredient in the cluster. There are only few such firms like, e.g., 
Horizonte Venture Management. The main reason for this is the bank-dominated landscape 
with a preference for traditional credit instruments and a widespread adversity to risk taking. 
Consequently, successful companies like Intercell or Igeneon had to attract external financing 
from international venture capitalists and funds.  
 
Vienna has an excellent scientific base comprising five universities, several hospitals and a 
range of other public and private research institutes. There is the Institute of Molecular 
Pathology (IMP) which is Boehringer Ingelheim’s cancer research centre. The Novartis 
Research Institute (NRI) was founded in the 1970. The Antibiotic Research institute Vienna 
(ABRI) is another privately owned basic research institute owned by Biochemie Kundl (part 
of Sandoz R&D). In the recent past a further strengthening of the local research base could be 
observed as the Austrian Academy of Sciences has established two new institutes, namely the 
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Institute of Molecular Biotechnology (IMBA) and the Research Centre for Molecular 
Medicine (CeMM) Moreover, in the recent past also five co-operative research centres 
between university institutes and firms have been set up. Besides research and provision of 
scientific knowledge the universities located in the region of Vienna also fulfill an important 
function as a source of highly skilled labour. Moreover, the General Hospital Vienna is also 
home of the Vienna School of Clinical Research (VSCR) giving postgraduate training to 
physicians. In the recent past, the education and training system has become further 
differentiated. In order to meet the growing demand for skilled biotechnology technicians 
several advanced technical colleges were founded. However, their alumni is not yet of 
considerable size. 
 
3.2 Knowledge Links in the Vienna Biotechnology Cluster 
This section summarises the main results of our analysis of knowledge flows within the 
Vienna biotechnology industry and between the local cluster and the outside world (for a 
more detailed discussion of our findings see Tödtling and Trippl 2005). We differentiate 
between market relations, formal collaborations and networks, spillovers and informal 
networks, spin-off processes, and labour market recruitment and mobility. Spin-off processes 
and labour market recruitment and mobility belong to the group of knowledge spillovers. 
Given their importance in the Vienna biotechnology cluster they will be dealt with separately 
in the following. Other types of knowledge externalities will be discussed jointly with 
informal networks (milieu) as in practice they could not always be clearly differentiated from 
each other. Table 3 provides an overview about our key results on the relevance of different 
types of knowledge links and their geography. Not included in Table 3 are labour market 
recruitment and mobility. This is due to the fact that our results on that issue are mainly 
qualitative in nature. 
 
Spillovers and milieu 
New firm formation constitutes an important mechanism for local knowledge transfer in the 
Vienna biotech cluster. The overwhelming majority of all spin-out companies originated from 
from academic institutions operating in the region, whereas firms have played only a minor 
role as incubators so far (see Table 4).  
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Table 3: Types of knowledge links and their geography in the Vienna biotechnology cluster 
 
 Total local national  international 
 Number of 
links 
With 
firms 
With 
RO 
Total With 
firms 
With 
RO 
Total With 
firms 
With 
RO 
Total 
Spillovers and 
milieu            
Spin-Offs 15 (8%) 3 11 14 0 0 0 1 0 1 
Other spillovers 40 (21%) 6 10 16 0 0 0 15 9 24 
            
Networks 79 (43%) 14 25 39 2 5 7 17 17 33 
              
Markets links  30 (16%) 2 8 10 0 0 0 13 7 20 
Other relations 22 (12%) 1 6 7 0 0 0 7 8 15 
              
 186 (100%)   86   7   93 
RO ... research organisation (universities, clinics)  
 
Table 4: Characterisation of spin-offs in the sample 
 
  Vienna 
  number of 
companies 
in % 
not older than 5 years 9 60 
not older than 10 years 4 27 
older than 10 years 2 13 
Age of firm 
Total 15 100 
Local 14 93 
National 0 0 
International 1 7 
Location of 
parent 
organisation 
Total 15 100 
Academic institution 11 73 
Firm 4 27 
Type of parent 
organisation 
Total 15 100 
1-10 8 53 
11-50 5 33 
Firm size 
(number of 
employees) more than 50 2 13 
 Total 15 100 
 
An analysis of the age of companies and firm size shows that most spin-off companies are not 
older than 5 years and many of them are very small employing less than 10 workers. Labour 
market recruitment and labour mobility of highly-skilled employees are also crucial for the 
circulation of knowledge in the Vienna biotech industry. For a large majority of the 
companies in our dataset the local labour market is an important external knowledge source. 
However, a more differentiated analysis has demonstrated that it is mainly the local 
universities that play an important role in this respect. Local inter- firm mobility is a rare 
phenomenon leading to a weak fluctuation of skilled workers within the system and little 
knowledge exchange among companies via this channel. Also the inflow of international 
scientific knowledge and managerial expertise could be observed. The latter is of particular 
 13 
importance as there is the lack of local managerial know-how in the cluster. Apart from spin-
offs and labour mobility there are also other spillovers, informal networks and milieu effects 
giving rise to knowledge flows in the Vienna biotechnology cluster. The geography of these 
flows reflects a coexistence of highly localised untraded interdependencies and international 
knowledge spillovers. The significance of the region in this respect results to a considerable 
extent from a rather intense informal networking between some local companies and research 
organisations within the cluster. Also between some few local firms people-based informal 
links could be identified. Knowledge spillovers are only partially geographically bounded. 
Several companies rated the reading of international scientific literature and patent 
specifications as rather important for getting access to new knowledge and for identifying and 
selecting partners for distant connections. Furthermore, international congresses and fairs 
have been identified to be crucial for monitoring the activities of international competitors and 
for establishing informal links to them and other distant firms. Interestingly, some evidence 
was also found that sometimes venture capitalists are vital information sources providing 
relevant “news” about international competitors and othe r firms to the local companies they 
are funding. 
 
Formal cooperations and networks 
Formal cooperations and networks constitute the most important type of knowledge flows in 
the Vienna biotech cluster. Almost 45% of all relations examined could be classified as such 
formal networks and they could be observed both at the local and global level. At the local 
level close network links between academic institutions and firms have been found. One the 
one hand there are several cooperations between university institutes, big pharma and young 
biotech firms that are financially supported by the Austrian government. These include the 
competence center “BioMolecular Therapeutics” (BMT), the Austrian Center for 
Biopharmaceutical Technology (ACBT) and two Christian Doppler Laboratories. 
Furthermore, there is evidence of a range of formal knowledge linkages between local 
universities and companies which have emerged spontaneously. Also partnerships among 
local firms such as joint projects between bioinformatics service providers and therapeutic 
firms seem to play a role in the Vienna biotechnology cluster. Innovation networks and R&D 
collaborations are far from being confined to the local level. The case of the Vienna 
biotechnology cluster clearly illustrates the importance of non- local connections as source of 
innovativeness in this industry. As our interviews have shown international universities, 
clinics and other research institutes are important partners in these networks. Furthermore, the 
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biotechnology firms in the Vienna region are also inserted into various innovation networks 
and R&D co-operations with foreign multinational pharmaceutical companies and young 
biotechnology firms.  
 
Market relations and other linkages 
There is some evidence that the companies of the Vienna biotechnology cluster make use of 
knowledge and expertise which can be “bought in the market place”. About 15% of all 
contacts identified could be classified as “market relations”. Table 3 illustrates that market 
links have been mainly found at the international level. Local interactions of this type play 
only a minor role by comparison. Some biotechnology companies have reported market 
relations with local university institutes and hospitals, whereas these links are largely about 
contract research, the testing of assays and the buying of patents and licenses. Partly due to 
the relative youth and the small size of the cluster, market relations between local firms are 
almost negligible. The international level clearly plays a stronger role than the local one. The 
Vienna biotech companies have some market links with international universities and clinics 
including the buying of patents and licenses as well as some contract research. Furthermore, 
some firms have close contacts to foreign commercial R&D firms, other clinical research 
organisations and international companies, from which patents and licenses have been bought. 
Finally, a number of relationships (12% of all links) have been found (see Table 3) which 
could not be subsumed to one of three main categories of links. This is due to the fact that the 
interview partners were not able or refused to characterise the relation. At the local level most 
of these links are with universities, whereas at the international level both companies and 
research organisations play a role as partners in these knowledge interactions. 
 
 
4 The role of policy in promoting knowledge links in the Vienna 
biotechnology cluster 
There are three policy levels influencing the development of the biotech cluster in Vienna (see 
Figure 2). Although Figure 2 does not include all institutions, programmes and initiatives, it 
displays the overall structure of the policy and supporting system. At the supranational level, 
EU programmes support and drive biotech related research through calls and funding. 
Moreover, legislation regarding biotechnology safe research as well as regulations of medical 
drug approval and clinical trials also play governing roles. The Austrian policy and supporting 
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system consists of national and regional institutions. Its strength lies in horizontal policies, 
which are not specifically designed to promote biotech but nevertheless have an impact on the 
development of its knowledge base through calls, grants and funding of research institutions 
(Reiss et al. 2003). 
 
Focusing on the third research question, we are now going to investigate how public policy 
initiatives are contributing to the formation, existence and functioning of knowledge links. 
We selected those programmes that most clearly support the creation of knowledge flows 
within the clus ter and listed them in Table 5 below. One has to realise, however, that most 
programmes can, and many times do, impact several types of knowledge interactions. To 
trace all possible direct and indirect impacts of every policy action, however, would be a too 
complex task. Thus, for every programme shown in the following we only marked the 
knowledge link with the strongest relevance. A more detailed display of the knowledge 
interactions these programmes or organisations promote is found in their descriptions, which 
also discusses the instruments they use to achieve the particular goals. 
 
4.1 National programmes 
The national policy level plays an outstanding role in fostering knowledge links in the Vienna 
biotechnology cluster. There are a variety of different policy measures and instruments in this 
respect. Many of them, however, are not biotechnology specific but aim at encouraging 
technological development per se. There are just two programmes which specifically focus on 
the promotion of biotechnology. These include the Austrian Genome Research Programme 
(GEN-AU) and the initiative Life Science Austria (LISA). 
 
GEN-AU has been initiated in 2001 by the Ministry of Education, Science and Culture with a 
budget of 10,5 million Euros per year until 2010. It has the mission to strengthen genome 
research in Austria by funding interdisciplinary cooperative research projects undertaken by 
academic and/or industrial research teams. Consequently, its main focus is on facilitating 
dynamic and formal knowledge flows (networks) between regional and/or national partners. 
So far 27.8 million Euros have been allocated to 23 projects run by 91 partner organisations.  
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Figure 2: Overview of the different policy systems governing Vienna biotechnology 
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The majority of the funded institutions are located in Vienna, but a number of research teams 
in other Austrian provinces are receiving financial support, too. LISA is a programme of the 
Austrian Business Agency (AWS) launched in 1999 on behalf of two federal ministries. It 
mainly attempts to support local and national knowledge spillovers via the foundation of new 
biotech companies by providing financial support, advice and education. LISA consists of 
several components:  
 
· LISA Preseed provides funds up to 100,000 Euros for a period of three years to potential 
entrepreneurs to establish the proof of principle. 
· Moreover, LISA offers information and advice to firm founders with respect to 
technological and commercial issues. 
· Best Of Biotech (BOB) is a business plan competition promoting the entrepreneurial 
activity of researchers in bioscience related fields. Its goal to increase the number of 
young life science firms by stimulating researchers to translate their ideas into business 
plans. BOB provides participants with advice and coaching with respect to prepare a 
business plan.  
· Furthermore, lectures and training sessions are organised to enhance the commercial and 
managerial competencies of scientists. 
· Finally, through the “Life Science Circles” meetings it also stimulates the informal 
exchange of ideas and experiences among actors. This is of particular importance in terms 
of enhancing milieu effects in the Vienna region. 
 
Since 1999 in sum about 35 new firm foundations in the field of life sciences have been 
supported, a large majority of which have settled down in the Vienna region.  
 
At the national level we can find many other initiatives which are of relevance for the purpose 
of this paper. Although they were not specifically designed to promote biotechnology, they 
nevertheless contribute to its development. There are, for instance, several programmes set up 
by the AWS that aim to advance high technology entrepreneurship. These include the 
initiatives “Seedfinancing” (loans), “High Tech Double Equity” (acceptance of guarantees) 
and “uni:venture”. The latter is a fund established by the bank BAWAG but managed by the 
AWS. 
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Table 5: Policy programmes stimulating knowledge links 
Types of knowledge links 
 
static dynamic 
Programme 
 
Organisation 
 
Intention: 
promotion of ... 
 
Key instruments 
market links spillovers networks milieu 
National programmes        
GEN-AU Min. for Education, Science 
and Culture 
collaboration funding   X  
LISA Austrian Business Agency       
   Life Science Circles  local interactions meetings, conferences    X 
   LISA-Preseed  new firm formation funding  X   
   Best-of-Biotech  new firm formation competition  X   
Tecma Austrian Business Agency patenting & licencing Counselling, evaluating, 
funding 
X    
Uni-invent Austrian Business Agency patenting & licencing Promoting, training scouts, 
funding, patent accounting   
X    
Seed financing Austrian Business Agency new firm formation provision of loans  X   
Uni-venture Austrian Business Agency& 
BAWAG 
new firm formation provision of venture capital  X   
i2b Austrian Research Promotion 
Agency 
links between business 
angels and companies 
brokering   X  
Brain Power Austria Austrian Research Promotion 
Agency 
international labour inflow information, advice, 
funding 
 X   
Christian Doppler Labs Min. of Economics and 
Labour, members 
university-industry 
partnerships 
funding   X  
European and international 
programmes 
Austrian Research  
Promotion Agency 
RDT cooperation information, advice, 
searching for partners 
  X  
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Types of knowledge links 
 
static dynamic 
Programme 
 
Organisation 
 
Intention: 
promotion of ... 
 
Key instruments 
market links spillovers networks milieu 
Regional programmes        
Infrastructure provision Center for Innovation and 
Technology  
new firm formation provision of space  X   
ZIT 05 plus Center for Innovation and 
Technology  
      
   Vienna Spot of Excellence  university-industry 
partnerships 
funding   X  
   Innovations-Support  cooperation funding   X  
   Technologienetzwerke  networks funding   X  
   Start-Up  new firm formation funding  X   
Joint regional and national programmes       
LISA VR Austrian Business Agency & 
Center for Innovation and 
Technology  
cluster formation and 
growth 
cluster management 
services 
 X   
INITS (AplusB) Austrian Research Promotion 
Agency & Center for 
Innovation and Technology  
new firm formation information, advice  X   
Kplus Austrian Research Promotion 
Agency & Center for 
Innovation and Technology  
collaboration in basic 
research 
funding   X  
Knet/Kind Austrian Research Promotion 
Agency & Center for 
Innovation and Technology  
collaboration in applied 
research 
funding   X  
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It provides venture capital to academic spin-offs. Companies can receive up to 1.1 million 
Euros for a period of 10 years. “uni:venture” contains a total funding volume of 7.2 million 
Euros. These initiatives clearly foster spillovers and informal knowledge flows at the regional 
and national level. 
 
Furthermore, there are the programmes “tecma” and “uni:invent” by which the AWS supports 
universities, researchers and companies to patent and license their research results. This is 
done by providing expertise, training as well as funding support for patenting. Moreover it is 
engaged in searching for license deals. These services, being free of charge, are an important 
precondition for universities and companies to go into market links or possible alliances with 
other partners. Moreover, these initiatives may indirectly promote spin-offs, as universities 
can utilise the licences or patents on their own. 
 
“Brain Power Austria” is a programme carried out by the Austrian Research Promotion 
Agency” (FFG) on behalf of the Ministry for Transport, Innovation and Technology. It has 
the goal to attract talented Austrian scientist from abroad. Thus, it promotes global knowledge 
spillovers. Scientists who are currently living or working abroad are assisted in looking for 
career opportunities in Austria. The main activities in this respect include amongst others the 
provision of financial support, relocation services and coaching but also a promotion of 
Austrian job opportunities.  
 
Furthermore, the FFG actively promotes the participation of Austrian firms and research 
organisations in interna tional cooperative RTD projects. More specifically it provides 
information and assistance relating to the Framework Programme of the EU, EUREKA and 
INTAS. Key activities include creating awareness, motivating, informing, and assisting on 
European Union and international research and technology activities, informing and coaching 
for preparing projects, as well as informing on issues of eligibility, evaluation criteria and 
procedural administrative and legal aspects. It also assists in searching for partners in 
collaborative EU and EUREKA projects. In addition, as the coordinator of the Innovation 
Relay Centre Austria, the FFG is actively involved in the transfer of new technologies and in 
other measures supporting innovation.  
 
The Christian-Doppler-Society, founded in 1989, promotes the collaboration between 
universities, research institutions and industrial partners for a length up to 7 years. 
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Specifically, it has the aim of bridging basic and applied research in a certain area. Although 
it sets out for a more general programme, it has two specifically targeting research in red 
biotechnology in the Vienna region. Thus, the programme is a promoter of interactive links in 
form of co-operations and networks. 
 
4.2 Regional programmes 
For a long time Vienna’s economic policy was about providing subsidies to individual 
companies and attracting multinational firms. It was only by the end of the 1990s that a 
stronger focus on innovation and technology could be observed. Today, Vienna’s strategic 
policy priorities are on life sciences, ICT, creative industries and the automotive sector. This 
reorientation of policy has been accompanied by a process of institution building. In 2000 the 
Centre for Innovation and Technology (ZIT) was established. Among its main activities are 
the funding of R&D activities of high tech companies. One year later the Vienna Science and 
Technology Fund (WWTF) was set up to provide financial support to research organisations. 
Both funding agencies have special programmes for biotechnology organised as contests of 
proposals, thus following a “picking the winner” approach. Looking specifically at the 
promoting of knowledge links in biotechnology, the ZIT turns out to be the key institution. 
One the one hand, it provides infrastructure (laboratories, offices) to newly founded firms, 
thus advancing knowledge spillovers in form of spin offs. On the other hand it has recently 
launched a comprehensive funding programme (ZIT 05 plus) that consists of several 
initiatives that are designed to be key drivers of formal and dynamic knowledge links at the 
regional level: 
 
· The initiative “Vienna Spots of Excellence” aims at promoting longer term university 
industry partnerships. 
· The new programme “Innovationssupport“ provides funding for initiating and preparing 
partnerships with educational institutes as well as for cooperations in the fields of 
production, marketing and distribution. 
· In order to support the formation and existence of networks in specific technological 
fields or centres the programme „Technologienetzwerke“ has been launched. It provides 
funding for all networking activities that contribute to the success of the innovation 
network (e.g. information services, events, publications). 
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· Finally, the programme „Start Up“ aims at supporting the formation of research intensive 
enterprises by funding R&D projects of young companies. 
 
4.3 Joint programmes between regional and national policy levels 
In the recent past, regional policy-makers have managed to build up strong links with national 
actors, thus improving vertical coordination between the regional and national policy levels. 
The “Life Science Austria Vienna Region” (LISA VR) represents a good example in this 
respect, as it is a joint initiative between the ZIT and the AWS. LISA VR provides cluster 
management services to the local biotech industry and acts as a “one stop shop”. By bundling 
the support available at federal and local levels, it offers a variety of services including 
consulting, pre seed financing, education and mediation of incubation space. As an actor in 
the system it stimulates static knowledge trans fer, more specifically spin-offs. Furthermore it 
also promotes non- local formal and informal knowledge flows by participating in 
international fairs and promoting the cluster in relevant international media sources.  
 
The national AplusB programme has the task to support regions to establish centres that focus 
on the stimulation of new firm formation. In the case of Vienna this led to the creation of 
INITS. This centre has been founded in 2003 by the ZIT and two universities with the aim to 
promote technology-oriented spin-offs from the academic sector in Vienna by offering 
incubation space, counselling and assistance, specifically to academia, in the process of 
turning a good idea into a viable business. In this process, it promotes knowledge spillovers in 
terms of spin-offs. 
 
The programmes Kplus and Knet/Kind focus on the formation of cooperative research centres 
between university institutes and companies. Both programs were initiated in the second half 
of the 1990s by national ministries. Funding for the centres, however, comes not only from 
the national policy level but also from the regional one (in the case of Vienna, ZIT). The 
programmes demand a minimum of 5 partners and have a limit of 7 years, some of which 
were described in Section 3.2. Kplus has the general strategic goal of enhancing knowledge 
(basic research) within a specific discipline whereas Knet/Kind has the goal of innovating 
within the specific discipline (applied research). In terms of the knowledge link analysis, 
these programs promote primarily formal networks. 
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4.4 Discussion 
In the recent past biotechnology has attracted a lot of interest from policymakers in Austria 
and in the Vienna region. Compared to many other nations and regions, however, the support 
for this highly science based sector comes late. As already outlined above, it was only by the 
end of the 1990s that systematic efforts to promote the biotechnology sector can be observed. 
This might be explained with the fact that Austria has no tradition and little experience in 
promoting high tech industries. Whilst having a good research base, its national and regional 
innovation systems have not been ripe for breeding a strong and dynamic biotech sector as 
early and fast as it could be observed elsewhere. In the last years, however, an intensive 
stimulation of biotechnology set in, brought about by a deep institutional change. There exists 
now a broad range of activities to foster start-ups and knowledge links in this sector, 
indicating that policy actors act like spiders in the web. An analysis of all these measures 
reveals the following patterns: 
 
· There are only few initiatives that focus specifically at encouraging the biotechnology 
industry. Horizontal measures and policy programmes which aim at stimulating high tech 
development per se clearly dominate. It is difficult to assess all these activities, as a large 
majority of them is rather young. Consequently, in most cases it is still not possible to 
determine their specific impact.  
· A strong concentration on promoting formal networks and entrepreneurship (spillovers) 
could be observed, whereas the stimulation of other types of knowledge links such as 
market relations and informal interactions (milieu) play only a minor role. This orientation 
has both a positive and a negative side. Given the youth and small size of the cluster a 
focus on new firm foundation seems to be a sound strategy as it contributes to coping with 
the challenge to reach a critical mass of young firms. Nevertheless, other types of 
knowledge links such as labour mobility and informal contacts might not be ignored as 
they are also essential for a dynamic development of biotech clusters. National and 
regional policymakers in Austria seem to assume to a too large extent that they always 
arise spontaneously. Thus, we might conclude that the policy and support system is 
strongly oriented at fostering formal networks and the creation of new ventures.  
· Furthermore, the overall set of policy measures is characterised by a strong focus on 
promoting regional and national knowledge interactions. In comparison, only few policy 
initiatives such as “Brainpower” and the actions undertaken by the BIT are designed to 
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explicitly stimulate international knowledge flows. The competence centre programmes 
Kplus and Kind/net as well as the CD Lab’s welcome international partners but do not 
explicitly enforce it or have special initiatives to encourage international partnerships. As 
we have pointed out above, knowledge sources from outside the region or nation are 
considered to play a crucial role in securing the growth and innovativeness of biotech 
clusters. To place too much emphasis on local and national interactions as it is observable 
in Austria and the Vienna region might have detrimental effects in the long run as it raises 
the danger of lock- ins. 
· Looking at the types of instruments in use it is clearly visible that more traditional 
approaches such as funding and provision of infrastructure are still very important. They 
are, however, combined with newer forms of intervention such as brokering, advice and 
cluster management services, resulting in a relatively balanced mix of older and newer 
modes of governance.  
· It is obvious that national policymakers play a key role in the multi level governance 
system. Nevertheless, the regional policy level must not be neglected, as it plays a 
complementary role. Furthermore, there is a good vertical coordination in the policy and 
supporting system that manifests itself in the establishment of the initiative LISA Vienna 
region. Interestingly, a comparison of the policy actions undertaken at the regional and 
national level shows some unexpected results: National policymakers adopt a broader 
strategy, focusing on the promotion of many different types of knowledge links including 
collaboration, informal contacts, new firm formation, international labour inflow etc. 
Furthermore, they fulfil various tasks such as financing and funding, brokering as well as 
provision of information and advice. They, thus, play a multifarious role. At the regional 
policy level, in contrast, the focus is narrower, as new firm formation and formal networks 
are the key targets with funding as the main instrument. This is somewhat astonishing as 
in most cases it is in particular the regional level where softer forms of intervention can be 
observed. We might conclude that policy makers in the Vienna region are addressing 
important barriers for the development of the biotechnology industry but are so far not 
using the full spectrum of instruments which might be derived from cluster theories and 
innovation system approaches. 
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5 Conclusions 
Many studies have shown that government services and programmes are of utmost 
significance in moving the biotechnology sector forward. The key tasks of public policy 
comprise the funding of universities and the R&D system, training and education, support for 
entrepreneurship, and the commercialisation of science, arrangements to ensure the 
availability of finance, etc. Policy makers are also important agents for facilitating knowledge 
sharing and networking in the innovation process. This paper endeavoured to highlight the 
role of policy in promoting knowledge interactions in the biotechnology industry. Despite the 
significance of such ties in this sector and the policy efforts devoted to them, there is still a 
limited understanding of how different government initiatives from various policy levels 
contribute to their formation. 
 
To reflect the role of the state as facilitator of knowledge interactions preconditions a fine 
grasp of how knowledge is transferred and exchanged in biotechnology. Drawing on a 
comprehensive model of knowledge flows based on the formal / informal character and the 
static or dynamic features of such links, a distinction between market relations, formal 
networks, knowledge spillovers and milieu effects has been drawn.  
 
For the emerging Vienna biotechnology cluster it has been shown that innovation is the 
outcome of a complex interplay of various types of relations at different spatial scales. 
Knowledge spillovers and informal milieu effects have been found to be significant, but more 
formalised network relationships are the most frequent type. Both the local and the global 
levels are relevant spaces for innovation relations. Different from most studies we found that 
informal relations (milieu or “buzz”) are not exclusively local and that formal networks or 
cooperations (“pipelines”) are not predominantly global. Instead, we demonstrated that 
innovation in the Vienna biotech sector is stimulated and supported by “buzz” and “pipelines” 
both at local and global levels. 
 
In the past few years a variety of different policy measures and instruments have been created 
to stimulate the formation of knowledge linkages in the Vienna biotechnology cluster. Many 
of these initiatives are designed to promote formal networks and entrepreneurship (spillovers), 
whereas the stimulation of market relations and milieu effects play only a minor role. 
Consequently, policy agents play a strong role as supporters of networks and intensifiers of 
positive externalities, but rarely act as facilitators of market links and animators of milieu 
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effects. Overall, a strong orientation of policy makers on promoting regional and national 
knowledge interactions could be observed and little has been done so far to encourage 
international knowledge flows which are of utmost importance for young biotechnology 
clusters in non high technology regions. Furthermore, in terms of government modes it has 
been demonstrated that traditional instruments such as funding and the provision of 
infrastructure are combined with modern forms of intervention, covering activities such as 
brokering, advice or cluster management services. Many of the programmes have been 
initiated by national policy agents. Some of them are executed jointly with regional 
authorities, reflecting a good vertical coordination in the policy and supporting system. Also 
the regional policy level plays an important role, even if it still does not use the full spectrum 
of instruments. It is in particular the softer forms of intervention which are a missing 
ingredient at the regional policy level so far. 
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